Brief: Medmira Receives The CE Mark For Its Reveal TP (Syphilis) And Starts Clinical Trials In Canada
09/03/2022 13:21
March 9 (Reuters) - MedMira Inc MIR.V :
* MEDMIRA RECEIVES THE CE MARK FOR ITS REVEAL® TP (SYPHILIS) AND STARTS
CLINICAL
TRIALS IN CANADA
Source text for Eikon: ID:nGNX1nW20s
Further company coverage: MIR.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on MedMira
See all newsSamsung Pay to stop working with Russia's Mir payment system from April 3
US targets Russia with hundreds of sanctions over Ukraine war, Navalny death (updated)
Motorcycling-Pirro to replace Bastianini at Ducati for Americas GP (updated)
Uzbekistan halts use of Russia's Mir payment cards (updated)
Uzbekistan halts use of Russia's Mir payment cards